PDLIUnknown
PDL BIOPHARMA, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for PDL BIOPHARMA, INC. (PDLI), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are PDLI insiders buying or selling?
PDL BIOPHARMA, INC. insiders reported no open-market purchases or sales in the last 12 months. Since November 2020, Trabud has recorded 17 Form 4 filings for PDLI: 6 buys ($31.9M) and 11 sells ($3.9M).
Source: SEC EDGAR Form 4
Key Statistics (November 2020 – Feb 3, 2021)
Total Form 4 filings
17
SEC EDGAR
Insider filers
7
Insider buys (6)
$31.9M
Insider sells (11)
$3.9M
Insider sentiment
Net buyingNet insider flow of $28.0M in net buying since November 2020.
Recent PDLI insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Feb 3, 2021 | Silver Point Capital L.P. | 10% Owner | Purchase | 187.1K | $2.05 | $383.5K | SEC ↗ |
| Jan 4, 2021 | Silver Point Capital L.P. | 10% Owner | Purchase | 6.3M | $2.50 | $15.8M | SEC ↗ |
| Dec 31, 2020 | David W Gryska | Director | Sale | 20.0K | $2.74 | $54.8K | SEC ↗ |
| Dec 29, 2020 | Silver Point Capital L.P. | 10% Owner | Purchase | 631.6K | $2.69 | $1.7M | SEC ↗ |
| Dec 23, 2020 | Silver Point Capital L.P. | 10% Owner | Purchase | 1.6M | $2.60 | $4.1M | SEC ↗ |
| Dec 23, 2020 | John Peter Mclaughlin | Director | Sale | 327.9K | $2.61 | $855.8K | SEC ↗ |
| Dec 18, 2020 | Silver Point Capital L.P. | 10% Owner | Purchase | 1.7M | $2.59 | $4.5M | SEC ↗ |
| Dec 17, 2020 | Christopher Lewis Stone | VP, Gen. Counsel & Secretary | Sale | 200.0K | $2.56 | $512.0K | SEC ↗ |
| Dec 17, 2020 | Dominique Monnet | President and CEO | Sale | 500.0K | $2.60 | $1.3M | SEC ↗ |
| Dec 17, 2020 | David W Gryska | Director | Sale | 75.0K | $2.68 | $201.0K | SEC ↗ |
| Dec 16, 2020 | Silver Point Capital L.P. | 10% Owner | Purchase | 2.1M | $2.57 | $5.4M | SEC ↗ |
| Dec 5, 2020 | David W Gryska | Director | Sale | 75.0K | $2.52 | $189.0K | SEC ↗ |
| Nov 25, 2020 | Elizabeth G. O'Farrell | Director | Sale | 25.8K | $2.44 | $63.0K | SEC ↗ |
| Nov 25, 2020 | David W Gryska | Director | Sale | 50.0K | $2.43 | $121.5K | SEC ↗ |
| Nov 21, 2020 | Elizabeth G. O'Farrell | Director | Sale | 63.3K | $2.38 | $150.7K | SEC ↗ |
| Nov 21, 2020 | Alan Lee Bazaar | Director | Sale | 33.4K | $2.42 | $81.0K | SEC ↗ |
| Nov 19, 2020 | David W Gryska | Director | Sale | 150.0K | $2.40 | $359.5K | SEC ↗ |
Showing the 17 most recent of 17 Form 4 filings for PDL BIOPHARMA, INC..
Most active PDLI insiders
- Silver Point Capital L.P.6 filings
- David W Gryska5 filings
- Elizabeth G. O'Farrell2 filings
- Alan Lee Bazaar1 filing
- Christopher Lewis Stone1 filing
Ask anything about PDLI insider activity
Use Trabud's AI agent to query PDL BIOPHARMA, INC.'s Form 4 history in plain English — "Show me PDLI CEO purchases this year" or compare it against any other ticker.
Open the AI agentPDLI insider trading FAQ
Are PDL BIOPHARMA, INC. insiders buying or selling?
PDL BIOPHARMA, INC. insiders reported no open-market purchases or sales in the last 12 months. Since November 2020, Trabud has recorded 17 Form 4 filings for PDLI: 6 buys ($31.9M) and 11 sells ($3.9M). Over the full record that is net buying of $28.0M.
How many insiders trade PDLI stock?
7 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for PDL BIOPHARMA, INC.. The most recent filing was accepted on Feb 3, 2021.
Where does Trabud get PDLI insider trading data?
All PDLI insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.